Adverse effect
hideIn medicine, an adverse effect is a harmful and undesired effect resulting from a medication or other intervention such as surgery. An adverse effect may be termed a "side effect", when judged to be secondary to a main or therapeutic effect, and may result from an unsuitable or incorrect dosage or procedure, which could be due to medical error. Adverse effects are sometimes referred to as "iatrogenic" because they are generated by a physician/treatment. Some adverse effects only occur only when starting, increasing or discontinuing a treatment. Using a drug or other medical intervention which is contraindicated may increase the risk of adverse effects. Adverse effects may cause medical complications of a disease or procedure and negatively affect its prognosis. They may also lead to non-compliance with a treatment regimen.
The harmful outcome is usually indicated by some result such as morbidity, mortality, alteration in body weight, levels of enzymes, loss of function, or as a pathological change detected at the microscopic, macroscopic or physiological level. It may also be indicated by symptoms reported by a patient. Adverse effects may cause a reversible or irreversible change, including an increase or decrease in the susceptibility of the individual to other chemicals, foods, or procedures, such as drug interactions.
In clinical trials, a distinction is made between adverse events (AEs) and serious adverse events (SAEs). Generally, any event which causes death, permanent damage, birth defects, or requires hospitalization is considered an SAE. The results of these trials are often included in the labeling of the medication to provide information both for patients and the prescribing physicians.
For more information about Adverse effect, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with side effects
Study confirms that cannabis is beneficial for multiple sclerosis
Medicine & Health / Neuroscience
Dec 04, 2009 |
5 / 5 (17) |
0
Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spa ...
Drug shows positive responses, low side-effects in multiple myeloma
Dec 07, 2009 |
not rated yet |
0
NEW ORLEANS ― The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers ...
Second-line CML drugs evoke faster response than front-line therapy
Dec 07, 2009 |
not rated yet |
0
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University ...
GAO: FDA yet to make safety changes post-Vioxx
Medicine & Health / Medications
2 hours ago |
not rated yet |
0
(AP) -- The Food and Drug Administration still hasn't restructured its staff to better monitor drug safety, more than three years after experts recommended key changes in the wake of the Vioxx scandal.
Search results for side effects
Glaxo's swine flu shot may give kids fever
Medicine & Health / Medications
Dec 04, 2009 |
not rated yet |
0
(AP) -- The European Medicines Agency warns that young children given GlaxoSmithKline's swine flu shot may get a fever after their second dose.
High-risk women reluctant to take tamoxifen to prevent breast cancer, study finds
Dec 03, 2009 |
1 / 5 (1) |
1
Even when women at high-risk of breast cancer are well-informed about the risks and benefits of using the drug tamoxifen for prevention, only 6 percent said they were likely to take it.
Drug shows promise for T315I-mutated chronic myeloid leukemia
Dec 07, 2009 |
not rated yet |
0
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. ...
Delivering medicine directly into a tumor
Dec 07, 2009 |
not rated yet |
0
Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara have identified a peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal ...
Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy
Dec 02, 2009 |
not rated yet |
0
Constraint-induced movement therapy (CIMT) is a potentially effective form of intervention for children with hemiplegic cerebral palsy, but more research is needed, according to a new systematic review published in the November ...
MSU researcher studies effects of experimental depression medication
Medicine & Health / Psychology & Psychiatry
Dec 02, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Michigan State University researcher is leading a clinical trial on an experimental medication he hopes will give doctors another weapon in the fight against depression and prove to be more effective among ...
By feeding the birds, you could change their evolutionary fate
Dec 03, 2009 |
4.2 / 5 (6) |
5
Feeding birds in winter is a most innocent human activity, but it can nonetheless have profound effects on the evolutionary future of a species, and those changes can be seen in the very near term. That's ...
Small addition to cancer drug may make big difference
15 hours ago |
3 / 5 (2) |
0
University of Florida researchers have found a way to use just a fraction of the normal dosage of a highly toxic, debilitating chemotherapy drug to achieve even better results against colon cancer cells.
New computer model could lead to safer stents
Dec 02, 2009 |
not rated yet |
0
(PhysOrg.com) -- After suffering heart attacks, patients often receive stents designed to hold their arteries open. Some of these stents release drugs that are meant to halt tissue growth in arteries, but ...
Higher risk for heart disease and diabetes associated with androgen deprivation therapy
Dec 07, 2009 |
not rated yet |
0
Men of all ages treated for prostate cancer with androgen deprivation therapy, specifically with gonadotropin-releasing hormone agonists (GnRH), have an increased risk of diabetes and cardiovascular disease, according to ...
List of search results for side effects
